提示: 手机请竖屏浏览!

糖尿病足溃疡及其再发
Diabetic Foot Ulcers and Their Recurrence


David G. Armstrong ... 糖尿病 • 2017.06.15
相关阅读
• 下肢溃疡的评估与管理 • 高压氧对于治疗慢性糖尿病足溃疡无效

影响下肢的糖尿病并发症常见、复杂而又花费巨大。糖尿病足溃疡是最广为人知的并发症。一项在英国西北部进行的社区研究中,在筛选阶段,糖尿病患者中活动性足溃疡的患病率为1.7%,年发病率为2.2%1。以下人群的年发病率更高:在作为美国老年医疗保险(Medicare)受益人的糖尿病人群中发病率为6.0%,在美国退伍军人的糖尿病人群中发病率为5.0%,在全球糖尿病患者人群中的发病率为6.3%2-4。根据2015年国际糖尿病联盟(International Diabetes Federation)5的患病率数据估计,每年全球发生糖尿病足溃疡的人数约为910万~2,600万。当然,患糖尿病并有足溃疡史的患者比例高于患活动性溃疡的患者比例;有3.1%~11.8%的糖尿病患者,或全球1,290万~4,900万,美国100万~350万的糖尿病患者有足溃疡史1,5-7。糖尿病足溃疡的终生发病率据过去估计约为糖尿病患者中的15%~25%8,但考虑到新的数据,实际可能会影响19%~34%的糖尿病患者(具体计算见补充附录,补充附录与本文全文可在NEJM.org获取)。





作者信息

David G. Armstrong, D.P.M., M.D., Ph.D., Andrew J.M. Boulton, M.D., and Sicco A. Bus, Ph.D.
From the Southern Arizona Limb Salvage Alliance (SALSA), Department of Surgery, University of Arizona College of Medicine, Tucson (D.G.A.); Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom (D.G.A., A.J.M.B.); and the Department of Rehabilitation Medicine, Academic Medical Center, University of Amsterdam, and Amsterdam Movement Sciences — both in Amsterdam (S.A.B.).Address reprint requests to Dr. Armstrong at SALSA, Department of Surgery, University of Arizona College of Medicine, 1501 N. Campbell Ave., Tucson, AZ 85724, or at armstrong@usa.net.

 

参考文献

1. Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377-384

2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med 2017;49:106-116

3. Margolis DJ, Malay DS, Hoffstad OJ, et al. Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006 to 2008 — diabetic foot ulcers: Data points #2. Rockville, MD: Agency for Healthcare Research and Quality, 2011.

4. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care 2006;29:1202-1207

5. Diabetes atlas. 7th ed. Brussels: International Diabetes Federation, 2015 (http://www.diabetesatlas.org).

6. History of foot ulcer among persons with diabetes — United States, 2000–2002. MMWR Morb Mortal Wkly Rep 2003;52:1098-1102

7. Scottish Diabetes Survey Monitoring Group. Scottish Diabetes Survey 2014 (http://diabetesinscotland.org.uk/Publications/SDS2014.pdf).

8. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-228

9. Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med 2016;33:1493-1498

10. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study. Diabetologia 2007;50:18-25

11. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132-e173

12. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435-1438

13. Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg 2014;59:220-34.e1

14. Ward R, Dunn J, Clavijo L, Shavelle D, Rowe V, Woo K. Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores. Ann Vasc Surg 2017;38:84-89

15. Lavery LA, Hunt NA, Ndip A, Lavery DC, Van Houtum W, Boulton AJ. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care 2010;33:2365-2369

16. Iversen MM, Tell GS, Riise T, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care 2009;32:2193-2199

17. Skrepnek GH, Mills JL Sr, Lavery LA, Armstrong DG. Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. Diabetes Care 2017 May 11 (Epub ahead of print)

18. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabet Med 2014;31:1498-1504

19. Barshes NR, Sigireddi M, Wrobel JS, et al. The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle 2013;4:4-4

20. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007;4:286-287

21. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010;52:Suppl:17S-22S

22. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046

23. Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev 2012;28:574-600

24. Bus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev 2016;32:Suppl 1:99-118

25. Hinchliffe RJ, Brownrigg JR, Andros G, et al. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev 2016;32:Suppl 1:136-144

26. Bus SA, Armstrong DG, van Deursen RW, Lewis JE, Caravaggi CF, Cavanagh PR. IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diabetes Metab Res Rev 2016;32:Suppl 1:25-36

27. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease: the EURODIALE Study. Diabetologia 2008;51:747-755

28. Dubský M, Jirkovská A, Bem R, et al. Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup. Int Wound J 2013;10:555-561

29. Bus SA, Waaijman R, Arts M, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care 2013;36:4109-4116

30. Ulbrecht JS, Hurley T, Mauger DT, Cavanagh PR. Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care 2014;37:1982-1989

31. Morbach S, Icks A, Rümenapf G, Armstrong DG. Comment on: Bernstein. Reducing foot wounds in diabetes. Diabetes Care 2013;36:e48. Diabetes Care 2013;36:e62-e62

32. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993;233:485-491

33. Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002;287:2552-2558

34. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care 2007;30:14-20

35. Plank J, Haas W, Rakovac I, et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care 2003;26:1691-1695

36. Lincoln NB, Radford KA, Game FL, Jeffcoate WJ. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008;51:1954-1961

37. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-1378

38. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers: a randomized clinical trial. J Bone Joint Surg Am 2003;85-A:1436-1445

39. Armstrong DG, Fiorito JL, Leykum BJ, Mills JL. Clinical efficacy of the pan metatarsal head resection as a curative procedure in patients with diabetes mellitus and neuropathic forefoot wounds. Foot Ankle Spec 2012;5:235-240

40. Kloos C, Hagen F, Lindloh C, et al. Cognitive function is not associated with recurrent foot ulcers in patients with diabetes and neuropathy. Diabetes Care 2009;32:894-896

41. Ghanassia E, Villon L, Thuan Dit Dieudonné JF, Boegner C, Avignon A, Sultan A. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care 2008;31:1288-1292

42. Monami M, Longo R, Desideri CM, Masotti G, Marchionni N, Mannucci E. The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms. J Am Podiatr Med Assoc 2008;98:130-136

43. Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications 2007;21:341-349

44. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med 2005;22:1306-1309

45. Helm PA, Walker SC, Pullium GF. Recurrence of neuropathic ulceration following healing in a total contact cast. Arch Phys Med Rehabil 1991;72:967-970

46. Gershater MA, Pilhammar E, Apelqvist J, Alm Roijer C. Patient education for the prevention of diabetic foot ulcers. Interim analysis of a randomised controlled trial due to morbidity and mortality of participants. Eur Diabetes Nurs 2011;8:102b-107b

47. Armstrong DG, Mills JL. Toward a change in syntax in diabetic foot care: prevention equals remission. J Am Podiatr Med Assoc 2013;103:161-162

48. Verdin C, Rao N. Exploring the value of a podiatric consult in palliative wound care. J Palliat Med 2017;20:6-6

49. Bus SA. Priorities in offloading the diabetic foot. Diabetes Metab Res Rev 2012;28:Suppl 1:54-59

50. Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55

51. Boulton AJ. Diabetic foot — what can we learn from leprosy? Legacy of Dr Paul W. Brand. Diabetes Metab Res Rev 2012;28:Suppl 1:3-7

52. Waaijman R, de Haart M, Arts ML, et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care 2014;37:1697-1705

53. Bus SA, van Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev 2016;32:Suppl 1:16-24

54. Lavery LA, Hunt NA, Lafontaine J, Baxter CL, Ndip A, Boulton AJ. Diabetic foot prevention: a neglected opportunity in high-risk patients. Diabetes Care 2010;33:1460-1462

55. Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess 2015;19:1-210

56. Peters EJ, Armstrong DG, Lavery LA. Risk factors for recurrent diabetic foot ulcers: site matters. Diabetes Care 2007;30:2077-2079

57. van Netten JJ, Price PE, Lavery LA, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev 2016;32:Suppl 1:84-98

58. Morbach S, Kersken J, Lobmann R, Nobels F, Doggen K, Van Acker K. The German and Belgian accreditation models for diabetic foot services. Diabetes Metab Res Rev 2016;32:Suppl 1:318-325

59. Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med 2007;120:1042-1046

60. Lavery LA, Higgins KR, Lanctot DR, et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004;27:2642-2647

61. Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999;22:1428-1431

62. Cisneros LL. Evaluation of a neuropathic ulcers prevention program for patients with diabetes Rev Bras Fisioter 2010;14:31-37. (In Portuguese.)

63. Hamonet J, Verdié-Kessler C, Daviet JC, et al. Evaluation of a multidisciplinary consultation of diabetic foot. Ann Phys Rehabil Med 2010;53:306-318

64. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg 1998;37:460-466

65. Armstrong DG, Holtz K, Wu S. Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study. Int Wound J 2005;2:166-170

66. Viswanathan V, Madhavan S, Rajasekar S, Chamukuttan S, Ambady R. Amputation prevention initiative in South India: positive impact of foot care education. Diabetes Care 2005;28:1019-1021

67. Calle-Pascual AL, Durán A, Benedí A, et al. Reduction in foot ulcer incidence: relation to compliance with a prophylactic foot care program. Diabetes Care 2001;24:405-407

68. Lavery LA, LaFontaine J, Higgins KR, Lanctot DR, Constantinides G. Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients. Adv Skin Wound Care 2012;25:519-524

69. Viswanathan V, Madhavan S, Gnanasundaram S, et al. Effectiveness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. Diabetes Care 2004;27:474-477

70. Busch K, Chantelau E. Effectiveness of a new brand of stock ‘diabetic’ shoes to protect against diabetic foot ulcer relapse: a prospective cohort study. Diabet Med 2003;20:665-669

71. Reike H, Bruning A, Rischbieter E, Vogler F, Angelkort B. Recurrence of foot lesions in patients with diabetic foot syndrome: influence of custom-molded orthotic device. Diabet Stoffwechsel 1997;6:107-113

72. Rizzo L, Tedeschi A, Fallani E, et al. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Low Extrem Wounds 2012;11:59-64

73. Chantelau E, Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med 1994;11:114-116

74. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 1998;15:412-417

75. Armstrong DG, Rosales MA, Gashi A. Efficacy of fifth metatarsal head resection for treatment of chronic diabetic foot ulceration. J Am Podiatr Med Assoc 2005;95:353-356

76. Armstrong DG, Lavery LA, Vazquez JR, et al. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes. Diabetes Care 2003;26:3284-3287

77. Vanlerberghe B, Devemy F, Duhamel A, Guerreschi P, Torabi D. Conservative surgical treatment for diabetic foot ulcers under the metatarsal heads: a retrospective case-control study Ann Chir Plast Esthet 2014;59:161-169. (In French.)

78. Faglia E, Clerici G, Caminiti M, Curci V, Somalvico F. Feasibility and effectiveness of internal pedal amputation of phalanx or metatarsal head in diabetic patients with forefoot osteomyelitis. J Foot Ankle Surg 2012;51:593-598

79. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev 2016;32:Suppl 1:195-200

80. Armstrong DG, Bharara M, White M, et al. The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes Metab Res Rev 2012;28:514-518

81. Bus SA. The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence. Plast Reconstr Surg 2016;138:Suppl:179S-187S

82. Bus SA, Haspels R, Busch-Westbroek TE. Evaluation and optimization of therapeutic footwear for neuropathic diabetic foot patients using in-shoe plantar pressure analysis. Diabetes Care 2011;34:1595-1600

83. Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers. Diabetes Care 2017 May 2 (Epub ahead of print)

服务条款 | 隐私政策 | 联系我们